August 26, 2016 7:42 PM ET

Biotechnology

Company Overview of Retrophin, Inc.

Executive Profile

Cornelius E. Golding

Director, Member of Audit Committee and Member of Compensation Committee, Retrophin, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
68$297,473

Background

Mr. Cornelius E. Golding, also known as Neal, serves as a Financial Consultant for property casualty insurance companies. Mr. Golding has extensive experience as a certified public accountant. He served as Chief Financial Officer and Senior Vice President at Atlantic Mutual Insurance Company since August 1994 until his retirement in September 2003. He served in various roles at Atlantic Mutual Insurance Company from 1981 to 2003, including Comptroller and Senior Vice ...

Corporate Headquarters

12255 El Camino Real
San Diego, California 92130

United States

Phone: 760-260-8600
Fax: --

Board Members Memberships

2006-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
2013-Present
Director, Member of Audit Committee and Member of Compensation Committee

Education

MBA
Fairleigh Dickinson University
Unknown/Other Education
St. John Fisher College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$48,125
Total Calculated Compensation$297,473
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
$973.5K
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$3.3M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director, Director and Chairman of Executive Committee
Shire plc
$4.3M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Retrophin, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.